NEWS
EverBlu’s Blumenthal accepts five-year ban and ASIC fine
SYDNEY: ormer Creso Pharmaceuticals and EverBlu Capital chair Adam Blumenthal has agreed to ... read more
SYDNEY: ormer Creso Pharmaceuticals and EverBlu Capital chair Adam Blumenthal has agreed to ... read more